Nancy Sullivan

Nancy Sullivan

CEO and Managing Director, Illinois Ventures

 

Nancy joined Illinois Ventures as CEO and Managing Director in 2013. Under her leadership, Illinois Ventures has invested in over 30 life science and technology ventures including Sfunga Therapeutics, Cystetic medicines, Actuate, Photonicare, Keywise AI, Psyonic, and Revolution Medicines (RVMD) which entered the public market in 2020. Nancy spent her early career in startup formation and technology commercialization with a focus on business development and deal generation. She is a graduate of Northwestern University where she earned an MBA from the Kellogg School of Management, as well as a MS in Biotechnology. She earned her BA from Loyola University.

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept